The advantage of chimeric antigen receptor T cell therapy in pediatric acute lymphoblastic leukemia with E2A-HLF fusion gene positivity: a case series

The E2A-HLF fusion gene is a very poor biomarker in acute lymphoblastic leukemia (ALL) because of its high relapse risk, even with the most intensive chemotherapy and hematopoietic stem cell transplantation (HSCT). Here, we analyzed four cases diagnosed with E2A-HLF fusion gene-positive B-ALL and tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Shuiyan, Lu, Jun, Su, Dongni, Yang, Fan, Zhang, Yongping, Hu, Shaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041607/
https://www.ncbi.nlm.nih.gov/pubmed/33880339
http://dx.doi.org/10.21037/tp-20-323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8041607/
https://www.ncbi.nlm.nih.gov/pubmed/33880339
http://dx.doi.org/10.21037/tp-20-323

Ejemplares similares